Table 2 Intragastric pH in mice with either a sham operation or oesophagitis.
| Genotype | Operation | Drug | Intragastric pH |
|---|---|---|---|
| VR‐1 (+/+) | Sham | 6.12 (0.89) | |
| VR‐1 (−/−) | Sham | 5.98 (0.95) | |
| VR‐1 (+/+) | Oesophagitis | 2.15 (0.43) | |
| VR‐1 (−/−) | Oesophagitis | 2.28 (0.33) | |
| VR‐1 (+/+) | Oesophagitis | Famotidine | 4.23 (1.53)** |
| VR‐1 (+/+) | Oesophagitis | Omeprazole | 5.81 (0.35)** |
| VR‐1 (+/+) | Oesophagitis | Capsazepine | 4.33 (0.80)** |
VR‐1, vanilloid receptor subtype 1.
A subset of mice were administered famotidine, omeprazole, or capsazepine. Note that sham operated mice did not have a significant reduction in intragastric pH, while both (+/+) and (−/−) mice with oesophagitis had a significant reduction in pH. Note the increase in pH levels following antisecretory and VR‐1 antagonism therapy.
Values are mean (SD).
**p<0.01 compared with VR‐1 (+/+).